Request Deal Involvement
Charles River Laboratories to acquire Vigene Biosciences from Signet for $350m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Davis Polk & Wardwell
legal advisors
Weil Gotshal and Manges
financial advisors
Robert W Baird
legal advisors
Sheppard Mullin Richter & Hampton
legal advisors
Shulman Rogers
or
Principals
vendor
SIGNET HEALTHCARE PARTNERS
bidder
CHARLES RIVER LABORATORIES INTERNATIONAL INC
target
VIGENE BIOSCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite